Detalles de la búsqueda
1.
Antithrombotic effects of ximelagatran plus acetylsalicylic acid (ASA) and clopidogrel plus ASA in a human ex vivo arterial thrombosis model.
Thromb Haemost
; 95(3): 447-53, 2006 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-16525572
2.
Effect of recombinant factor VIIa on melagatran-induced inhibition of thrombin generation and platelet activation in healthy volunteers.
Thromb Haemost
; 91(6): 1090-6, 2004 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-15175794
3.
No influence of mild-to-moderate hepatic impairment on the pharmacokinetics and pharmacodynamics of ximelagatran, an oral direct thrombin inhibitor.
Clin Pharmacokinet
; 42(8): 755-64, 2003.
Artículo
en Inglés
| MEDLINE | ID: mdl-12846596
4.
Ximelagatran, an oral direct thrombin inhibitor, has a low potential for cytochrome P450-mediated drug-drug interactions.
Clin Pharmacokinet
; 42(8): 765-77, 2003.
Artículo
en Inglés
| MEDLINE | ID: mdl-12846597
5.
Prevention of clot formation during haemodialysis using the direct thrombin inhibitor melagatran in patients with chronic uraemia.
Nephrol Dial Transplant
; 20(9): 1889-97, 2005 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-15928099
6.
Pharmacokinetics and pharmacodynamics of melagatran, the active form of the oral direct thrombin inhibitor ximelagatran, are not influenced by acetylsalicylic acid.
Eur J Clin Pharmacol
; 59(4): 283-9, 2003 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-12845508
Resultados
1 -
6
de 6
1
Próxima >
>>